Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total		Class A Common Stock	Common stock	Common stock Class A Common Stock	Common stock Class B Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ 799,269				$ 0	$ 0	$ 1,320,479	$ (553,337)	$ 7,724	$ 24,403
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2022					27,141,000	119,747,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)					55,368,000	(55,368,000)
Issuance of common stock related to vested exercised stock options (in shares)						1,386,000
Issuance of common stock related to vested exercised stock options	11,413						11,413
Issuance of common stock under employee stock purchase plan (in shares)					289,000
Issuance of common stock under employee stock purchase plan	9,554						9,554
Repurchases, net of early exercised stock options (in shares)						(19,000)
Issuance of common stock related to RSUs vested, net of tax withholdings (in shares)					227,000
Vesting of early exercised stock options	2,960						2,960
Stock-based compensation expense	55,218						52,246			2,972
Change in noncontrolling interest ownership due to capital contributions from noncontrolling interest holders, net of issuance costs	57,673						16,839			40,834
Deconsolidation of Meltano Inc.	(11,342)									(11,342)
Other comprehensive income (loss)	(6,315)								(4,268)	(2,047)
Net loss	(88,110)							(85,123)		(2,987)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2022					83,025,000	65,746,000
Stockholders' Equity, ending balance at Jul. 31, 2022	830,320				$ 0	$ 0	1,413,491	(638,460)	3,456	51,833
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	818,202				$ 0	$ 0	1,355,224	(579,436)	6,306	36,108
Stockholders' Equity, beginning balance (in shares) at Apr. 30, 2022					74,049,000	73,583,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)					8,461,000	(8,461,000)
Issuance of common stock related to vested exercised stock options (in shares)						652,000
Issuance of common stock related to vested exercised stock options	6,193						6,193
Issuance of common stock under employee stock purchase plan (in shares)					289,000
Issuance of common stock under employee stock purchase plan	9,554						9,554
Repurchases, net of early exercised stock options (in shares)						(28,000)
Issuance of common stock related to RSUs vested, net of tax withholdings (in shares)					226,000
Vesting of early exercised stock options	814						814
Stock-based compensation expense	37,747						34,992			2,755
Change in noncontrolling interest ownership due to capital contributions from noncontrolling interest holders, net of issuance costs	22,889						6,714			16,175
Other comprehensive income (loss)	(3,582)								(2,850)	(732)
Net loss	(61,497)							(59,024)		(2,473)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2022					83,025,000	65,746,000
Stockholders' Equity, ending balance at Jul. 31, 2022	830,320				$ 0	$ 0	1,413,491	(638,460)	3,456	51,833
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	830,320				0	0	1,413,491	(638,460)	3,456	51,833
Stockholders' Equity, beginning balance	$ 824,725	[1]			$ 0	$ 0	1,497,373	(725,648)	(705)	53,705
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2023					94,655,000	56,489,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)					7,358,000	(7,358,000)
Issuance of common stock related to vested exercised stock options (in shares)	2,062,000					2,060,000
Issuance of common stock related to vested exercised stock options	$ 17,933						17,933
Issuance of common stock under employee stock purchase plan (in shares)					247,000
Issuance of common stock under employee stock purchase plan	7,751						7,751
Repurchases, net of early exercised stock options (in shares)						(13,000)
Issuance of common stock related to RSUs vested, net of tax withholdings (in shares)					1,038,000
Charitable donation of common stock (in shares)			133,389	134,000
Charitable donation of common stock	5,350		$ 5,300				5,350
Vesting of early exercised stock options	809						809
Stock-based compensation expense	78,698						81,359			(2,661)
Change in noncontrolling interest ownership due to capital contributions from noncontrolling interest holders, net of issuance costs							(503)			503
Other comprehensive income (loss)	81								2,487	(2,406)
Net loss	(104,107)							(102,549)		(1,558)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2023					103,432,000	51,178,000
Stockholders' Equity, ending balance at Jul. 31, 2023	831,240	[1]			$ 0	$ 0	1,610,072	(828,197)	1,782	47,583
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	815,601				$ 0	$ 0	1,542,603	(778,117)	1,003	50,112
Stockholders' Equity, beginning balance (in shares) at Apr. 30, 2023					96,240,000	56,453,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)					6,213,000	(6,213,000)
Issuance of common stock related to vested exercised stock options (in shares)						940,000
Issuance of common stock related to vested exercised stock options	10,320						10,320
Issuance of common stock under employee stock purchase plan (in shares)					247,000
Issuance of common stock under employee stock purchase plan	7,751						7,751
Repurchases, net of early exercised stock options (in shares)						(2,000)
Issuance of common stock related to RSUs vested, net of tax withholdings (in shares)					679,000
Charitable donation of common stock (in shares)			52,647	53,000
Charitable donation of common stock	2,675		$ 2,700				2,675
Vesting of early exercised stock options	292						292
Stock-based compensation expense	46,368						46,555			(187)
Change in noncontrolling interest ownership due to capital contributions from noncontrolling interest holders, net of issuance costs							(124)			124
Other comprehensive income (loss)	(559)								779	(1,338)
Net loss	(51,208)							(50,080)		(1,128)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2023					103,432,000	51,178,000
Stockholders' Equity, ending balance at Jul. 31, 2023	831,240	[1]			$ 0	$ 0	1,610,072	(828,197)	1,782	47,583
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ 831,240	[1]			$ 0	$ 0	$ 1,610,072	$ (828,197)	$ 1,782	$ 47,583

[1] (1) As of July 31, 2023 and January 31, 2023, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $52.5 million and $62.8 million, respectively, and liabilities of $7.3 million and $8.9 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion.